Stephan Windecker

Showing 1-20 of 157 articles

Author Sarah Bär

Are all DES equal at 10-year follow-up?

Bär S, Windecker S, Räber L

December 6, 2019 | 10.4244/EIJV15I11A176

Author Henning Kelbæk

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F-J, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

Author Corrado Tamburino

2019 – A leap year for valvular heart disease

Tamburino C, Piazza N, Baumbach A, Windecker S, Maisano F, Prendergast B

November 15, 2019 | 10.4244/EIJV15I10A154

Author Andreas Baumbach

Evolving paradigms in valvular heart disease: where should guidelines move?

Baumbach A, Dudek D, Baumgartner H, Windecker S, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00818

Author Tian-Yuan Xiong

Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography

Xiong T, Pighi M, Thériault-Lauzier P, Leipsic J, Spaziano M, Martucci G, Buithieu J, Mousavi N, Pilgrim T, Praz F, Windecker S, Chen M, Piazza N

November 15, 2019 | 10.4244/EIJ-D-19-00618

Author Giulia Costa

Interventions for valvular disease

Initial European experience with transcaval transcatheter aortic valve implantation

Costa G, De Backer O, Pilgrim T, Kasel M, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

October 29, 2019 | 10.4244/EIJ-D-19-00797

Author Kuniaki Takahashi

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Author Chun Chang

Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M-A, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser AG, Baumbach A, Serruys P

September 3, 2019 | 10.4244/EIJ-D-19-00552

Author Maria N Tovar Forero

Coronary interventions

Incidence and predictors of outcomes after a first definite coronary stent thrombosis

Tovar Forero MN, Zanchin T, Masdjedi K, van Zandvoort L, Kardys I, Zijlstra F, Häner J, Windecker S, Van Mieghem N, Räber L, Daemen J

September 3, 2019 | 10.4244/EIJ-D-19-00219

Author Caroline Kleinecke

Amplatzer left atrial appendage closure: access via transseptal puncture versus patent foramen ovale or atrial septal defect

Kleinecke C, Fuerholz M, Buffle E, de Marchi S, Schnupp S, Brachmann J, Nietlispach F, Fankhauser M, Streit SR, Windecker S, Meier B, Gloekler S

August 27, 2019 | 10.4244/EIJ-D-19-00442

Author Ply Chichareon

Coronary interventions

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Author Giuseppe Gargiulo

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Author Stephan Windecker

Interventional cardiology’s golden age of contributions to evidence-based medicine

May 20, 2019 | 10.4244/EIJV15I1A6

Author Uri Landes

Interventions for valvular disease

Transcatheter aortic valve-in-valve implantation in degenerative rapid deployment bioprostheses

Landes U, Dvir D, Schoels W, Tron C, Ensminger S, Simonato M, Schäfer U, Bunc M, Aldea GS, Cerillo A, Windecker S, Marzocchi A, Andreas M, Amabile N, Webb J, Kornowski R

May 20, 2019 | 10.4244/EIJ-D-18-00752

Author Salvatore Cassese

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

February 5, 2019 | 10.4244/EIJ-D-18-01080

Author Yuki Katagiri

Coronary interventions

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iniguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

Author Patrick Serruys

Interventions for valvular disease

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial

Serruys P, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra P, Kappetein AP, Onuma Y, Søndergaard L, Van Mieghem N

October 19, 2018 | 10.4244/EIJ-D-18-00460

Author Jonas Lanz

Interventions for valvular disease

Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access

Lanz J, Pilgrim T, Greenbaum A, Windecker S

October 19, 2018 | 10.4244/EIJ-D-18-00553

Author Marco Barbanti

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

Author Jonas Lanz

Current state of alternative access for transcatheter aortic valve implantation

Lanz J, Greenbaum A, Pilgrim T, Tarantini G, Windecker S

September 7, 2018 | 10.4244/EIJ-D-18-00552

1
2
3
...
8

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke